{
  "nctId": "NCT04352439",
  "briefTitle": "Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy",
  "officialTitle": "Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy",
  "protocolDocument": {
    "nctId": "NCT04352439",
    "filename": "Prot_SAP_002.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-06-01",
    "uploadDate": "2022-09-06T12:34",
    "size": 626557,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04352439/document/Prot_SAP_002.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 19,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2020-08-08",
    "completionDate": "2022-03-02",
    "primaryCompletionDate": "2022-03-02",
    "firstSubmitDate": "2020-04-13",
    "firstPostDate": "2020-04-20"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Khorana score = 1\n* Over age 18\n* English-speaking female patients\n* Able to consent\n* Receiving neoadjuvant chemotherapy Cancer of primary ovarian, fallopian tube, mullerian, or peritoneal origin\n\nExclusion Criteria:\n\n* Allergy or intolerance to study medication\n* Indication for a non-aspirin form of antiplatelet (i.e. cardiac stent)\n* Already on alternative form of anticoagulation\n* Active bleeding\n* High risk for active bleeding (i.e. recent intracranial bleed or gastrointestinal bleed, known brain metastases)\n* Thrombocytopenia (platelets \\<50,000)\n* Unable to complete medication adherence diary\n* Unable to take oral medications",
    "healthyVolunteers": false,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of Participants Experiencing a Venous Thromboembolism",
        "timeFrame": "Up to six months"
      },
      {
        "measure": "Number of Participants With at Least One Adverse Event",
        "description": "Adverse events will only include those that are determined to be related to the study drug.",
        "timeFrame": "Up to six months"
      },
      {
        "measure": "Medication Adherence",
        "description": "Patient adherence to aspirin as defined by percent of pills used.",
        "timeFrame": "Up to six months"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:50.998Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}